# Chapter 05: Freeze Declaration & Certification Report

## 1. Router Sanity & Monotonicity Freeze Declaration

Phase C11.15 formally certifies and locks the empirical and mathematical sanity, single-input monotonicity, invariant stability, and pipeline contract separation of the ACARA-U dynamic multimodal router:

> **Phase C11.15 Status:** 🟢 SEALED & VERIFIED (16/16 Gates Passed)

---

## 2. Frozen Execution Envelope

| Parameter / Dimension | Sealed Value | Source of Truth | Status |
| :--- | :--- | :--- | :---: |
| **Router Version** | `acarau_v2.0` | `src/fusion/router/acarau_router.py` | LOCKED |
| **Routing Coefficients $\Theta_0$** | $(\alpha=1.0, \, \beta=1.5, \, \gamma=1.0, \, \eta=0.5)$ | Phase C11.12 Reference | LOCKED |
| **Decision Penalty $\delta^*$** | $0.10$ | Phase C11.13 Selection | LOCKED |
| **Cohort Context (Upstream Reference)** | $N=500, \, \text{seed}=115$ | Phase C11.1 Controlled Cohort | LOCKED |
| **Monotonicity Evaluation Grid** | 144 trials $\times$ 4 attributes ($576$ total) | Phase C11.15 Test Suite | LOCKED |
| **Simplex & Masking Invariants** | 700 Monte Carlo + 300 Masking Checks | Zero Violations ($\lvert \Delta w \rvert < 10^{-10}$) | LOCKED |
| **Cryptographic Manifest** | 3 Frozen JSON Artifacts (3/3 SHA-256 Verified) | `freeze_manifest.json` | SEALED |

---

## 3. Cryptographic Artifact Hashes & Certification Record

`freeze_manifest.json` anchors the three primary frozen generation artifacts (`protocol.json`, `test_results.json`, and `summary.json`). The independent verification record `certification_report.json` is generated at verification runtime, verifying the manifest and recording the SHA-256 checksums of all four files:

| Artifact | SHA-256 Checksum | Lifecycle State |
| :--- | :--- | :---:|
| `protocol.json` | `ad482027894391826aeaabc9b4bc402fcec7252f9511643160861653a85f5643` | Immutable Generation Protocol |
| `test_results.json` | `f27f8c38e859a760d5cde30f5f7237a7384109504dcf724e7c240d7d1f8bac70` | Frozen Raw Evidence |
| `summary.json` | `e4e295eef1355ed5be179a9d164d2eed28663076fc9de82ab7e43e911da3c857` | Generation-Time Summary |
| `freeze_manifest.json` | `47ec51fbfcb21aa8e0c069d1373ba25937d9b89b016c549a68c3314ba5394153` | Cryptographic Manifest (Anchors 3 primary artifacts) |
| `certification_report.json` | *Written upon independent verification* | Independent Verification Record (`CERTIFIED_AND_SEALED`) |

---

## 4. Verification Envelope Summary

| Gate Category | Evaluated Conditions | Gates Passed | Audit Verdict |
| :--- | :--- | :---: | :---: |
| **Manifest & Configuration Integrity** | Cryptographic hash manifest integrity & cross-artifact consistency (`S15-00`), Reference configuration integrity (`S15-01`) | 2 / 2 | PASS |
| **Single-Input Monotonicity** | Confidence (`S15-02`), Reliability (`S15-03`), Uncertainty (`S15-04`), Quality (`S15-05`) | 4 / 4 | PASS |
| **Mathematical Invariants** | Simplex (`S15-06`), Hard Masking (`S15-07`), Shift Invariance (`S15-08`), Permutation (`S15-09`), Stability & Input Validation (`S15-10`) | 5 / 5 | PASS |
| **Edge Cases & Contracts** | EMPTY fail-closed (`S15-11`), masked value invariance (`S15-12`), pipeline separation & production contract (`S15-13`) | 3 / 3 | PASS |
| **Regression & Fault Injection** | C11.14 regression suite (`S15-14`, 22/22 tests), 14 verifier mutation tests (`S15-15`, 14/14 named faults caught) | 2 / 2 | PASS |
| **Total C11.15 Envelope** | Complete Acceptance Matrix (`S15-00` through `S15-15`) | **16 / 16** | **SEALED** |

---

## 5. Scope Boundaries & Research Context

- **Mathematical Verification Scope:** All tests certify the algorithmic integrity and mathematical consistency of the ACARA-U routing kernel and decision pipelines under controlled numerical fixtures and the $N=500$ decision-packet benchmark context.
- **Downstream Production Execution:** Fused risk and DCRI calculations are executed directly through production modules (`src.fusion.dcri.aggregation` and `src.fusion.dcri.uncertainty_penalty`).
- **No Retuning:** Hyperparameter coefficients $\Theta_0$ and penalty $\delta^*$ were strictly frozen and not adjusted to optimize metrics.
- **Clinical Non-Efficacy Statement:** This benchmark is an in silico mathematical and operational analysis. It does not constitute evidence of clinical efficacy, diagnostic superiority, or patient-level safety.
